A privately-owned Healthcare AI Consulting Boutique focused on transforming the diagnosis, monitoring, and treatment of human diseases through Human-AI collaborations. We empower companies to drive scientific breakthroughs, transform rapidly, innovate intelligently, ​and leverage AI to unlock new potential.​ We serve MedTech startups, Pharma companies, VC firms, and leading organizations in the healthcare AI industry. We provide advisory services for developing, testing, implementing, and commercializing AI-driven pioneering solutions in drug development, remote patient monitoring, and precision medicine. Website coming soon...projected to launch Jan 2025.

Lapsi Health is a medical technology startup company that uses digital innovation to transform the way we listen, monitor, and interpret physiological sounds of the human body to advance the treatment and diagnostic of various medical conditions.

Mitsubishi Pharma is primary a client of mine with an affiliated advisory title. I work closely with the company leadership to help drive a multi-year global enterprise strategy for incorporating tech innovation, digital biomarkers, AI-based analytics approaches, and digital health solutions across the pipeline.

Driving Redenlab's clinical portfolio and global business strategy for speech biomarkers and voice analytics to evaluate the efficacy of pharmaceutical treatments and monitor the progression of neurodegenerative diseases.

Advising the company's leadership on the integration of Curebase's software and virtual site capabilities beyond DTx, diagnostics, and ePRO to more complex, global drug trials and large-scale biospecimen collection studies.

Bridge2AI Voice is a pioneering initiative at the forefront of advancing the use of voice biomarkers through ethical development of artificial intelligence. Our consortium is dedicated to fostering innovation, promoting ethical standards, and driving forward the application of AI voice technologies across various sectors.https://www.b2ai-voice.org/

SOLO is a startup company in the mental health market dedicated to the science of AI-powered emotional intelligence. The technology uses a smartphone camera to turn video data into real-time objective emotional insights based on natural facial biomarkers.

QuantifiCare offers a user-friendly mobile solution designed to capture images of skin reactions and monitor patients with various dermatology-related conditions. DermaPix® Mobile is a powerful, adaptable and scalable solution that can be integrated with various software platforms for decentralized trials in the pharma/biotech industry.

Serve as a Scientific Advisory Board Member supporting the integration of Castor's Decentralized Clinical Trial (DCT) solutions featuring a robust API, seamless EHR integration, plug-and-play design, native ePRO/eConsent service, and built-in image capture and video capability.

The Global Alzheimer’s Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to fostering digital health innovation and augmenting the use of digital phenotyping of people with or at risk for Alzheimer’s disease (AD).

EverythingALS is a non-profit organization dedicated to bringing technological innovations and digital data science to people living with ALS, by offering a open-data platform for direct engagement with patients, caregivers, researchers and pharma companies.

Click Tx is a biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Click’s Digital Therapeutics™ enables change within individuals through cognitive and neurobehavioral mechanisms.

• Leading the development and implementation of digital health solutions for Pfizer’s gene therapy programs in Duchenne Muscular Dystrophy and Friedreich’s Ataxia.• Developing clinical research and validation strategy to identify novel digital biomarkers and AI-based sensor intelligence.• Serving as point of contact and key contributor to digital-related regulatory submission to FDA/EMA. • Working closely with advocacy networks to organize advisory panels to elicit direct patient feedback and user input on prototype digital solutions intended to be used in future trials.

• As PI, provided executive oversight for developing study protocols, IRB submissions, and clinical research operation across multiple research teams. • Developed innovative bedside solutions for promoting healing environment and improving clinical care for intensive care patients. • Collaborated with physicians and biomedical engineers on clinical trial in high‐risk patient population.• Demonstrated success in leading/ mentoring a doctoral‐level team and 30 research trainees. • Established global partnerships between clinicians, scientists, and KOLs in the tech industry.• Authored 45 peer-reviewed publications, 40 grant proposals, and 50+ scientific presentations and invited talks worldwide.

Grateful for the opportunity to be the scientific medical advisor on this amazing project by Samsung inspired by babies (and some of my work too!)• Voice-enabled Technology for Preterm Newborns: served as clinical lead and senior author in support of the development of a mobile app designed to promote neurodevelopment in intensive care newborns using personalized audio recordings and womb-like maternal vocal stimulation• Served as lead consultant in support of the development of a sensory stimulation mobile application platform designed to improve cardiorespiratory stability and support sensory brain development in intensive care neonates using individualized recordings of womb-like maternal sounds. • Supported the development of two user-interfaces responsive to both clinicians and patients. • Advised management on strategic clinical trial planning and therapeutic value assessment.

• Clinical Trial Experience as PI: designed and managed research protocol for longitudinal clinical trials with complex endpoints, consented 300+ patients, 15+ IRB protocol submissions, directly responsible for research compliance, review and approval of regulatory documents and compliance safety reports.• Digital Technology Innovation: developed novel digital instruments and research tools for data collections, ensured scientific quality and integrity of data collections in clinical trials. • Data Analytics: analyzed and synthesized qualitative and quantitative data into actionable insights; published results using predictive analytics, image analysis, and statistical models.• Clinical Outcome Assessment: developed new digital instruments and research tools for data collections and inclusion in clinical studies, ensured scientific quality and integrity of data.• Academic achievements: 50+ peer‐reviewed publications and 25+ research grant.• Presentations: 125+ scientific presentations and invited talks for various stakeholders including, medical conferences, hospital grand rounds, and biomedical industry events across the US and Europe.

• Teaching: developed and taught a graduate‐level course covering the following topics: Prenatal exposures and brain development, Epidemiological Pharmacology, Perinatal epidemiology, Environmental factors and birth outcomes, Critical review and analysis of research studies, therapeutic effectiveness, and clinical evidence. • Toxicology and Pharmacology: developed a multifactorial model for neonatal drug exposure, demonstrating potentiation effects between environmental noise and aminoglycoside toxicity.

• Digital Bedside Device for Pain Management in Pediatric Cardiovascular Patients: awarded a grant to lead a unique collaboration between biomedical engineers, pediatric cardiologists, and cardiac surgeons in designing and examining the efficacy of a novel digital device that streams maternal voice stimulation intended to improve pain management in post-op babies in the cardiac ICU.

• Team Building and Management: demonstrated success in managing and mentoring 30 trainees and a 10-person doctoral-level cross-functional team in a matrix environment with large budget management. • Maternal and Newborn Research: as PI, provided executive oversight for several RCTs and medical device studies looking at health outcomes of 300+ mothers and babies in both inpatients/outpatients settings.• Brain Research: developed a newborn-friendly imaging protocol, combining brain MRI and cranial head ultrasound, to examine the effects of sensory experience in the neonatal period on neurodevelopment. • Impact of Noise Exposure on Brain Development: designed, performed, and published numerous studies examining the effects of noise exposure on cardiorespiratory stability, neurodevelopmental disabilities, and brain development in extremely preterm infants in the neonatal ICU.Relevant skills: Team Leading, Clinical Trials management, Scientific Writing and Review, Neurodevelopmental assessments in pediatric patients, Brain imaging, Cardiorespiratory outcomes in high‐risk patient population,Building strategic research roadmap, Clinical Evidence and Outcome Research, Budget Management, Managing clinical research operation, Supervising research teams, Developing operations manuals and staff training guidelines, Monitoring GCP and research compliance, Consenting and communicating with subjects/families, Reviewing and approval of regulatory documents, IRB submissions, and hospital safety compliance.

• Brain Recovery and Neuromusuclar Technology: as PI, developed a novel medical technology that uses adaptive sensory stimulation to improve motor function in stroke patients; performed clinical trials using brain imaging techniques to compare therapeutic effectiveness against traditional physical therapy.